An expanding view for the molecular basis of familial periodic paralysis

Neuromuscular Disorders

Volumn 12, Issue 6, 2002, Pages 533-543

  Cannon, Stephen C ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Andersen's syndrome; Ion channels; Myotonia; Paramyotonia; Skeletal muscle

Indexed keywords

ACETAZOLAMIDE; CALCIUM CHANNEL; POTASSIUM CHANNEL; SODIUM CHANNEL;

CLINICAL FEATURE; GENE MUTATION; GENETIC DISORDER; GLYCOGEN STORAGE DISEASE TYPE 4; HUMAN; HYPOKALEMIC PERIODIC PARALYSIS; MOLECULAR BIOLOGY; MOLECULAR GENETICS; PATHOPHYSIOLOGY; PERIODIC PARALYSIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; THOMSEN DISEASE;

CALCIUM CHANNELS; GENOTYPE; GLYCOGEN STORAGE DISEASE TYPE IV; HUMANS; MUSCLE, SKELETAL; MUTATION; PARALYSES, FAMILIAL PERIODIC; PHENOTYPE; POTASSIUM CHANNELS; SODIUM CHANNELS;

EID: 0036310758     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(02)00007-X     Document Type: Review

References (43)

1. Voltage-gated ion channels and hereditary disease
2. Ion channel defects in the hereditary myotonias and periodic paralyses
3. Ion channel mutations affecting muscle and brain
4. Muscle membrane potentials in episodica adynamia
5. The periodic paralyses and paramyotonia congenital
6. Hypokalaemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A
7. Intermittent muscular weakness, extrasystoles, and multiple developmental anomalies. A new syndrome?
8. Andersen's syndrome: Potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features
9. Andersen's syndrome: A distinct periodic paralysis
10. Two cases of adynamia episodica hereditaria: In vitro investigation of muscle cell membrane and contraction parameters
11. Hyperkalemic periodic paralysis and the adult muscle sodium channel alpha-subunit gene
12. Paramyotonia congenita and hyperkalemic periodic paralysis are linked to the adult muscle sodium channel gene
13. MiRP2 forms potassium channels in skeletal muscle with Kv3.4 and is associated with periodic paralysis
14. Mapping of the hypokalaemic periodic paralysis (HypoPP) locus to chromosome 1q31-32 in three European families
15. Dihydropyridine receptor mutations cause hypokalemic periodic paralysis
16. A calcium channel mutation causing hypokalemic periodic paralysis
17. A novel sodium channel mutation in a family with hypokalemic periodic paralysis
18. Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current
19. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome
20. A sodium channel defect in hyperkalemic periodic paralysis: Potassium-induced failure of inactivation
21. Spectrum of sodium channel disturbances in the nondystrophic myotonias and periodic paralyses
22. Sodium channel mutations in paramyotonia congenita uncouple inactivation from activation
23. Sodium channel mutations in paramyotonia congenita exhibit similar biophysical phenotypes in vitro
24. Inactivation defects caused by myotonia-associated mutations in the sodium channel III-IV linker
25. + channel mutation causing hyperkalemic periodic paralysis
26. + channel mutation associated with paramyotonia congenita in a human cell line
27. + channel inactivation must be disrupted to evoke prolonged depolarization-induced paralysis
28. Impaired slow inactivation in mutant sodium channels
29. Defective slow inactivation of sodium channels contributes to familial periodic paralysis
30. A double mutation in families with periodic paralysis defines new aspects of sodium channel slow inactivation
31. Hypokalemic periodic paralysis: In vitro investigation of muscle fiber membrane parameters
32. + current
33. 2+ ions in excitation-contraction coupling of skeletal muscle fibres
34. Calcium currents and transients of native and heterologously expressed mutant skeletal muscle DHP receptor alpha1 subunits (R528H)
35. Gating of the L-type Ca channel in human skeletal myotubes: An activation defect caused by the hypokalemic periodic paralysis mutation R528H
36. 2+ channel expressed in Xenopus laevis oocytes
37. Electrophysiological properties of the hypokalaemic periodic paralysis mutation (R528H) of the skeletal muscle alpha 1S subunit as expressed in mouse L cells
38. The calcium channel blocker verapamil in hypokalemic periodic paralysis
39. + channels in patients with hypokalemic periodic paralysis
40. Barium-treated mammalian skeletal muscle: Similarities to hypokalemic periodic paralysis
41. The human skeletal muscle Na channel mutation R669H associated with hypokalemic periodic paralysis enhances slow inactivation
42. Inhibition of rat ventricular IK1with antisense oligonucleotides targeted to Kir2.1 RNA
43. Targeted disruption of Kir2.1 and Kir2.2 genes reveals the essential role of the inwardly rectifying K(+) current in K(+)-mediated vasodilation